3D bioprinting has emerged as a powerful technology that can produce 3D biomedical structures, artificial tissues and organs imitating critical characteristics of a natural tissue or organ. Such printed 3D scaffolds find a broad spectrum of applications such as high-throughput drug screening, tissue engineering, regenerative medicine, organ transplantation, medical dressing for wound care as well as in vitro cell culturing studies for biomedical research. Our proposed Research to Business project 3D CelluGel aims to evaluate different business models in order to identify the best commercialization and business strategy for making our bioinks into an international success. We will strive to make our innovation as globally recognized 3D bioprinting material products. Our innovation will provide a highly profitable value-chain for bio-based economy and that is benefiting to economic feasibility of existing biorefinery processes in an integrated concept and of next-generation biorefinery concepts, for which several Finnish SMEs are standing. With targeted applications in several health-promoting applications the project is also expected to provide new lines of products to novel solutions for health.

2022

2024